Patents by Inventor Albert Park

Albert Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260137812
    Abstract: Described herein are synthetic promoters and/or enhancers that are specific for cancer cells and methods of engineering synthetic cancer-specific promoters.
    Type: Application
    Filed: January 16, 2026
    Publication date: May 21, 2026
    Inventors: Dariusz WODZIAK, Shireen RUDINA, Maggie C. LOUIE, Yue ZHANG, Elizabeth STROEBELE, Albert PARK, David SUHY
  • Patent number: 12582726
    Abstract: Described herein are synthetic promoters and/or enhancers that are specific for cancer cells and methods of engineering synthetic cancer-specific promoters.
    Type: Grant
    Filed: May 23, 2025
    Date of Patent: March 24, 2026
    Assignee: EARLI Inc.
    Inventors: Dariusz Wodziak, Shireen Rudina, Maggie C. Louie, Yue Zhang, Elizabeth Stroebele, Albert Park, David Suhy, Paul Escarpe, Cyriac Roeding, Justin Lin, Alex Harwig, Leland Harrison Hartwell
  • Publication number: 20250161496
    Abstract: Described herein are synthetic promoters and/or enhancers that are specific for cancer cells and methods of engineering synthetic cancer-specific promoters.
    Type: Application
    Filed: January 22, 2025
    Publication date: May 22, 2025
    Inventors: Dariusz WODZIAK, Shireen RUDINA, Maggie C. LOUIE, Yue ZHANG, Elizabeth STROEBLE, Albert PARK, David SUHY
  • Publication number: 20190160244
    Abstract: A bronchoscope includes a main shaft extending from a proximal end to a distal end having an aperture. The proximal end of the bronchoscope includes a plurality of ports. One port is a ventilation port in fluid communication with the main shaft via a ventilation tube. The ventilation tube includes a first portion and a second portion, wherein the second portion extends from the first portion to the main shaft. The second portion is disposed at angle of approximately 60-70 degrees relative to the first portion. Another port may be configured to receive an adapter that includes a first member and a second member, wherein the second member is rotatable relative to the first member to relocate a tool received by the adapter within the main shaft.
    Type: Application
    Filed: April 3, 2017
    Publication date: May 30, 2019
    Inventors: Trent PARRY, Kyle THORNLEY, Joshua BURTON, John NELSON, Albert PARK
  • Patent number: 10238599
    Abstract: A method of treating congenital cytomegalovirus (cCMV) induced hearing loss includes the step administering a composition to the mammal, wherein the composition consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and, optionally, a withanolide, and/or resveratrol.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: March 26, 2019
    Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: Josef M. Miller, Glenn E. Green, Barry Sheldon Seifer, Albert Park, Ali Ahmed Almishaal, Phayvanh Phithaksounthone Sjogren
  • Publication number: 20180008537
    Abstract: A method of treating congenital cytomegalovirus (cCMV) induced hearing loss includes the step administering a composition to the mammal, wherein the composition consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and, optionally, a withanolide, and/or resveratrol.
    Type: Application
    Filed: September 25, 2017
    Publication date: January 11, 2018
    Inventors: Josef M. Miller, Glenn E. Green, Barry Sheldon Seifer, Albert Park, Ali Ahmed Almishaal, Phayvanh Phithaksounthone Sjogren